1915
The second patient was a 32-year-old woman with HIV, anxiety disorder, and a history of intravenous drug abuse who developed increased sedation and mental confusion when an atazanavir-ritonavir-based antiretroviral regimen was added to her stable antianxiety drug regimen, which included quetiapine.
 a 32-year-old woman with HIV, anxiety disorder, and a history of intravenous drug abuse: Subject; 32-year-old: Subject.Age; woman: Subject.Gender; intravenous drug abuse: Subject.Disorder; increased sedation and mental confusion: Effect; atazanavir-ritonavir-based antiretroviral regimen was added to her stable antianxiety drug regimen, which included quetiapine: Treatment; quetiapine: Treatment.Drug; atazanavir: Treatment.Drug; ritonavir: Treatment.Drug; HIV: Treatment.Disorder; anxiety disorder: Treatment.Disorder; ritonavir: Combination.Drug; atazanavir: Combination.Drug; quetiapine: Combination.Drug
Given event type and trigger, please tell me the arguments of all the listed option. Output format is "name1: role1; name2: role2". 
Event type: adverse event 
  Option: Treatment.Freq, Subject.Population, Combination.Drug, Subject.Gender, Treatment.Duration, Subject, Effect, Treatment, Treatment.Disorder, Subject.Disorder, Treatment.Route, Subject.Race, Treatment.Time_elapsed, Treatment.Dosage, Subject.Age, Treatment.Drug 
Text: {0} 
Answer:
 a 32-year-old woman with HIV, anxiety disorder, and a history of intravenous drug abuse: Subject; 32-year-old: Subject.Age; woman: Subject.Gender; intravenous drug abuse: Subject.Disorder; increased sedation and mental confusion: Effect; atazanavir-ritonavir-based antiretroviral regimen was added to her stable antianxiety drug regimen, which included quetiapine: Treatment; quetiapine: Treatment.Drug; atazanavir: Treatment.Drug; ritonavir: Treatment.Drug; HIV: Treatment.Disorder; anxiety disorder: Treatment.Disorder; ritonavir: Combination.Drug; atazanavir: Combination.Drug; quetiapine: Combination.Drug